News | PharmaEssentia

Feb 9, 2026
Professional Article
Polycythemia Vera in Pregnancy: What Patients and Clinicians Should Know
Learn More
Feb 9, 2026
Professional Article
Cancer and Bruising: Why It Happens, and What It Means in Blood Cancer and Polycythemia Vera
Learn More
Feb 9, 2026
Professional Article
Polycythemia Vera Symptoms in Men: What to Look For
Learn More
Feb 9, 2026
Professional Article
Myeloproliferative Neoplasms (MPN) — Types, How They Differ, and What to Know
Learn More
Feb 9, 2026
Professional Article
Polycythemia Vera Is Not Cancer? Understanding the Debate
Learn More
Feb 9, 2026
Professional Article
Polycythemia Vera Lab Values: What Is and Isn't PV
Learn More
Feb 9, 2026
Professional Article
How Long Can You Have Polycythemia Vera Without Knowing?
Learn More
Feb 9, 2026
Professional Article
Hereditary Erythrocytosis vs Polycythemia Vera: Key Differences
Learn More
Feb 9, 2026
Professional Article
Understanding Bone Marrow Disorders: How Conditions Like Polycythemia Vera Begin
Learn More
Feb 9, 2026
Professional Article
Myeloproliferative Neoplasms Symptoms: What Patients Experience & How They Are Assessed
Learn More
Feb 8, 2026
Professional Article
Phlebotomy for Polycythemia Vera: Why It Lowers Risk and How It Works
Learn More
Feb 7, 2026
Professional Article
High Red Blood Cell Count Symptoms: What They Mean and When to Worry
Learn More
Feb 2, 2026
Professional Article
Secondary Polycythemia: Causes, Symptoms, and Treatment
Learn More
Jan 30, 2026
Professional Article
Essential Thrombocythemia vs Polycythemia Vera: Understanding MPNs
Learn More
Jan 23, 2026
Newsroom
The U.S. NCCN Guidelines Included Ropeginterferon alfa-2b-njft (P1101) as a Recommended Treatment Option for Patients with Essential Thrombocythemia (ET)
Learn More

Polycythemia Vera in Pregnancy: What Patients and Clinicians Should Know

Cancer and Bruising: Why It Happens, and What It Means in Blood Cancer and Polycythemia Vera

Polycythemia Vera Symptoms in Men: What to Look For

Myeloproliferative Neoplasms (MPN) — Types, How They Differ, and What to Know

Polycythemia Vera Is Not Cancer? Understanding the Debate

Polycythemia Vera Lab Values: What Is and Isn't PV

How Long Can You Have Polycythemia Vera Without Knowing?

Hereditary Erythrocytosis vs Polycythemia Vera: Key Differences

Understanding Bone Marrow Disorders: How Conditions Like Polycythemia Vera Begin

Myeloproliferative Neoplasms Symptoms: What Patients Experience & How They Are Assessed

Phlebotomy for Polycythemia Vera: Why It Lowers Risk and How It Works

High Red Blood Cell Count Symptoms: What They Mean and When to Worry

Secondary Polycythemia: Causes, Symptoms, and Treatment

Essential Thrombocythemia vs Polycythemia Vera: Understanding MPNs

The U.S. NCCN Guidelines Included Ropeginterferon alfa-2b-njft (P1101) as a Recommended Treatment Option for Patients with Essential Thrombocythemia (ET)